Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
Zhu Y, Liu Y, Zhang C, Chu J, Wu Y, Li Y, Liu J, Li Q, Li S, Shi Q, Jin L, Zhao J, Yin D, Efroni S, Su F, Yao H, Song E, Liu Q.
Zhu Y, et al. Among authors: liu j, liu y, liu q.
Nat Commun. 2018 Apr 23;9(1):1595. doi: 10.1038/s41467-018-03951-0.
Nat Commun. 2018.
PMID: 29686231
Free PMC article.